مصطلحات الفهرس: SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily B member 1/ec [Endogenous Compound], transcription factor EZH2/ec [Endogenous Compound], transcriptional regulator ATRX/ec [Endogenous Compound], transcriptome/ec [Endogenous Compound], unclassified drug, cdkn2a/b protein/ec [Endogenous Compound], h3f3a protein/ec [Endogenous Compound], kit protein/ec [Endogenous Compound], mycn protein/ec [Endogenous Compound], nf1 protein/ec [Endogenous Compound], nras protein/ec [Endogenous Compound], pdfgra protein/ec [Endogenous Compound], pik3ca protein/ec [Endogenous Compound], pik3r1 protein/ec [Endogenous Compound], PIK3R2 protein/ec [Endogenous Compound], rb1 protein/ec [Endogenous Compound], protein tyrosine phosphatase SHP 2/ec [Endogenous Compound], epidermal growth factor receptor/ec [Endogenous Compound], adult, article, cancer chemotherapy, cancer patient, cancer risk, cancer susceptibility, central nervous system tumor, childhood cancer/dt [Drug Therapy], chromosome 1q, chromosome arm, classifier, cohort analysis, controlled study, feasibility study, follow up, gene amplification, gene expression, germline mutation, hematologic malignancy, human, loss of function mutation, major clinical study, methylome, molecular fingerprinting, neuroblastoma, pilot study, point mutation, priority journal, prospective study, RNA sequencing, sarcoma, signal transduction, single nucleotide polymorphism, solid malignant neoplasm, treatment response, tumor associated leukocyte, whole genome sequencing, young adult, antineoplastic agent/cb [Drug Combination], antineoplastic agent/dt [Drug Therapy], ATM protein/ec [Endogenous Compound], BRG1 protein/ec [Endogenous Compound], cyclin dependent kinase 4/ec [Endogenous Compound], cyclin dependent kinase inhibitor/cb [Drug Combination], epidermal growth factor receptor 2/ec [Endogenous Compound], fibroblast growth factor receptor 1/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin complex 1/ec [Endogenous Compound], mammalian target of rapamycin complex 2/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/cb [Drug Combination], mammalian target of rapamycin inhibitor/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/cb [Drug Combination], nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase/ec [Endogenous Compound], protein/ec [Endogenous Compound], protein kinase B/ec [Endogenous Compound], protein p53/ec [Endogenous Compound], cyclin dependent kinase inhibitor/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26859Test
Nature Medicine
Click here for full text options
LibKey Link

مصطلحات الفهرس: SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily B member 1/ec [Endogenous Compound], transcription factor EZH2/ec [Endogenous Compound], transcriptional regulator ATRX/ec [Endogenous Compound], transcriptome/ec [Endogenous Compound], unclassified drug, cdkn2a/b protein/ec [Endogenous Compound], h3f3a protein/ec [Endogenous Compound], kit protein/ec [Endogenous Compound], mycn protein/ec [Endogenous Compound], nf1 protein/ec [Endogenous Compound], nras protein/ec [Endogenous Compound], pdfgra protein/ec [Endogenous Compound], pik3ca protein/ec [Endogenous Compound], pik3r1 protein/ec [Endogenous Compound], PIK3R2 protein/ec [Endogenous Compound], rb1 protein/ec [Endogenous Compound], protein tyrosine phosphatase SHP 2/ec [Endogenous Compound], epidermal growth factor receptor/ec [Endogenous Compound], adult, article, cancer chemotherapy, cancer patient, cancer risk, cancer susceptibility, central nervous system tumor, childhood cancer/dt [Drug Therapy], chromosome 1q, chromosome arm, classifier, cohort analysis, controlled study, feasibility study, follow up, gene amplification, gene expression, germline mutation, hematologic malignancy, human, loss of function mutation, major clinical study, methylome, molecular fingerprinting, neuroblastoma, pilot study, point mutation, priority journal, prospective study, RNA sequencing, sarcoma, signal transduction, single nucleotide polymorphism, solid malignant neoplasm, treatment response, tumor associated leukocyte, whole genome sequencing, young adult, antineoplastic agent/cb [Drug Combination], antineoplastic agent/dt [Drug Therapy], ATM protein/ec [Endogenous Compound], BRG1 protein/ec [Endogenous Compound], cyclin dependent kinase 4/ec [Endogenous Compound], cyclin dependent kinase inhibitor/cb [Drug Combination], epidermal growth factor receptor 2/ec [Endogenous Compound], fibroblast growth factor receptor 1/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin complex 1/ec [Endogenous Compound], mammalian target of rapamycin complex 2/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/cb [Drug Combination], mammalian target of rapamycin inhibitor/dt [Drug Therapy], Myc protein/ec [Endogenous Compound], nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/cb [Drug Combination], nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase/ec [Endogenous Compound], protein/ec [Endogenous Compound], protein kinase B/ec [Endogenous Compound], protein p53/ec [Endogenous Compound], cyclin dependent kinase inhibitor/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26859Test
Nature Medicine
LibKey Link

مصطلحات الفهرس: collagen/ec [Endogenous Compound], adiponectin/ec [Endogenous Compound], Western blotting, waist circumference, skeletal muscle, signal transduction, cross-sectional study, epidermal growth factor/ec [Endogenous Compound], collagen type 3/ec [Endogenous Compound], collagen type 1/ec [Endogenous Compound], aerobic exercise, anthropometric parameters, article, controlled study, exercise, female, fibrosis, gene expression, glucose homeostasis, glucose transport, human, hyperandrogenism, immunoblotting, insulin resistance, insulin sensitivity, insulin signaling, menstrual cycle, glucose transporter 4/ec [Endogenous Compound], insulin receptor substrate 1/ec [Endogenous Compound], leptin/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], muscle protein/ec [Endogenous Compound], oxidized low density lipoprotein receptor 1/ec [Endogenous Compound], peroxisome proliferator activated receptor gamma/ec [Endogenous Compound], protein kinase B/ec [Endogenous Compound], Smad2 protein/ec [Endogenous Compound], somatomedin C/ec [Endogenous Compound], testosterone/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], triacylglycerol/ec [Endogenous Compound], RNA extraction, real time polymerase chain reaction, protein phosphorylation, priority journal, ovary polycystic disease, observational study, obesity, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28866Test
Endocrine Connections
Click here for full text options
LibKey Link

مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

URL: International Journal of Molecular Sciences
Click here for full text options
LibKey Link

مصطلحات الفهرس: collagen/ec [Endogenous Compound], adiponectin/ec [Endogenous Compound], Western blotting, waist circumference, skeletal muscle, signal transduction, cross-sectional study, epidermal growth factor/ec [Endogenous Compound], collagen type 3/ec [Endogenous Compound], collagen type 1/ec [Endogenous Compound], aerobic exercise, anthropometric parameters, article, controlled study, exercise, female, fibrosis, gene expression, glucose homeostasis, glucose transport, human, hyperandrogenism, immunoblotting, insulin resistance, insulin sensitivity, insulin signaling, menstrual cycle, glucose transporter 4/ec [Endogenous Compound], insulin receptor substrate 1/ec [Endogenous Compound], leptin/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], muscle protein/ec [Endogenous Compound], oxidized low density lipoprotein receptor 1/ec [Endogenous Compound], peroxisome proliferator activated receptor gamma/ec [Endogenous Compound], protein kinase B/ec [Endogenous Compound], Smad2 protein/ec [Endogenous Compound], somatomedin C/ec [Endogenous Compound], testosterone/ec [Endogenous Compound], transforming growth factor beta/ec [Endogenous Compound], transforming growth factor beta1/ec [Endogenous Compound], triacylglycerol/ec [Endogenous Compound], RNA extraction, real time polymerase chain reaction, protein phosphorylation, priority journal, ovary polycystic disease, observational study, obesity, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28866Test
Endocrine Connections
LibKey Link

مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29021Test
International Journal of Molecular Sciences
LibKey Link

مصطلحات الفهرس: enzyme inhibition, focal glomerulosclerosis, glomerulus, glomerulus epithelium cell, human, human cell, human tissue, kidney function, kidney hypertrophy, morphometry, mouse, nonhuman, podocyte, protein function, cell loss, child, controlled study, diabetic nephropathy, albuminuria, animal cell, animal experiment, animal model, animal tissue, article, body growth, cell activation, cell regeneration, signal transduction, upregulation, mammalian target of rapamycin/ec [Endogenous Compound], adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35982Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: enzyme inhibition, focal glomerulosclerosis, glomerulus, glomerulus epithelium cell, human, human cell, human tissue, kidney function, kidney hypertrophy, morphometry, mouse, nonhuman, podocyte, protein function, cell loss, child, controlled study, diabetic nephropathy, albuminuria, animal cell, animal experiment, animal model, animal tissue, article, body growth, cell activation, cell regeneration, signal transduction, upregulation, mammalian target of rapamycin/ec [Endogenous Compound], adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35982Test
LibKey Link

مصطلحات الفهرس: controlled study, disease duration, disease severity, drug blood level, female, gene, gene expression, genetic transcription, human, human cell, in vitro study, major clinical study, male, onset age, peripheral blood mononuclear cell, signal transduction, treatment-resistant schizophrenia/dt [Drug Therapy], aged, upregulation, chlorpromazine/dt [Drug Therapy], clozapine/cr [Drug Concentration], clozapine/dt [Drug Therapy], epidermal growth factor receptor/ec [Endogenous Compound], epidermal growth factor receptor 2/ec [Endogenous Compound], epidermal growth factor receptor 3/ec [Endogenous Compound], epidermal growth factor receptor 4/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], neu differentiation factor/ec [Endogenous Compound], S6 kinase/ec [Endogenous Compound], AKT1 gene, eIF4EBP gene, ERBB1 gene, ERBB2 gene, ERBB3 gene, ERBB4 gene, mTOR gene, NRG ErbB signaling pathway, NRG2 gene, P70S6K gene, PIK3CD gene, PIK3R3 gene, article, adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38759Test
Frontiers in Psychiatry
Click here for full text options
LibKey Link

مصطلحات الفهرس: controlled study, disease duration, disease severity, drug blood level, female, gene, gene expression, genetic transcription, human, human cell, in vitro study, major clinical study, male, onset age, peripheral blood mononuclear cell, signal transduction, treatment-resistant schizophrenia/dt [Drug Therapy], aged, upregulation, chlorpromazine/dt [Drug Therapy], clozapine/cr [Drug Concentration], clozapine/dt [Drug Therapy], epidermal growth factor receptor/ec [Endogenous Compound], epidermal growth factor receptor 2/ec [Endogenous Compound], epidermal growth factor receptor 3/ec [Endogenous Compound], epidermal growth factor receptor 4/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], neu differentiation factor/ec [Endogenous Compound], S6 kinase/ec [Endogenous Compound], AKT1 gene, eIF4EBP gene, ERBB1 gene, ERBB2 gene, ERBB3 gene, ERBB4 gene, mTOR gene, NRG ErbB signaling pathway, NRG2 gene, P70S6K gene, PIK3CD gene, PIK3R3 gene, article, adult, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38759Test
Frontiers in Psychiatry
Click here for full text options
LibKey Link